(CLRB) Cellectar Biosciences - Performance -91.9% in 12m
Compare CLRB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-88.88%
#170 in Group
Rel. Strength
1.04%
#7874 in Universe
Total Return 12m
-91.92%
#195 in Group
Total Return 5y
-98.32%
#175 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: CLRB (-91.9%) vs XBI (-14.9%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: CLRB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CLRB
| Total Return (including Dividends) | CLRB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -11.39% | 2.77% | 5.69% |
| 3 Months | -14.10% | -14.21% | -6.49% |
| 12 Months | -91.92% | -14.88% | 9.72% |
| 5 Years | -98.32% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | CLRB | XBI | S&P 500 |
| 1 Month | -59.7% | 57% | 89.4% |
| 3 Months | -36.1% | -82.3% | -72% |
| 12 Months | -89.0% | -53.1% | 49.3% |
| 5 Years | -85.5% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #168 | -13.8% | -16.2% |
| 3 Month | #41 | 0.13% | -8.14% |
| 12 Month | #196 | -90.5% | -92.6% |
| 5 Years | #176 | -97.7% | -99.2% |
FAQs
Does CLRB Cellectar Biosciences outperforms the market?
No,
over the last 12 months CLRB made -91.92%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months CLRB made -14.10%, while XBI made -14.21%.
Over the last 3 months CLRB made -14.10%, while XBI made -14.21%.
Performance Comparison CLRB vs Indeces and Sectors
CLRB vs. Indices CLRB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -7.18% | -17.1% | -83.2% | -102% |
| US NASDAQ 100 | QQQ | -7.45% | -18.8% | -83.6% | -103% |
| US Dow Jones Industrial 30 | DIA | -7.07% | -14.1% | -82.2% | -98.2% |
| German DAX 40 | DAX | -7.63% | -26.5% | -109% | -117% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -7.41% | -14.3% | -82.4% | -98.2% |
| Hongkong Hang Seng | HSI | -10.1% | -26.3% | -92.7% | -100% |
| India NIFTY 50 | INDA | -3.48% | -14.6% | -85.1% | -94.0% |
| Brasil Bovespa | EWZ | -10.2% | -23.0% | -92.4% | -85.7% |
CLRB vs. Sectors CLRB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -6.55% | -17.9% | -89.4% | -112% |
| Consumer Discretionary | XLY | -8.60% | -18.1% | -81.0% | -107% |
| Consumer Staples | XLP | -6.32% | -12.1% | -90.1% | -99.2% |
| Energy | XLE | -9.43% | -15.9% | -77.2% | -82.9% |
| Financial | XLF | -7.88% | -18.2% | -89.1% | -113% |
| Health Care | XLV | -3.08% | -8.33% | -78.0% | -85.9% |
| Industrial | XLI | -8.11% | -19.7% | -84.2% | -102% |
| Materials | XLB | -7.34% | -16.4% | -79.1% | -85.8% |
| Real Estate | XLRE | -6.39% | -18.3% | -85.6% | -105% |
| Technology | XLK | -8.02% | -21.1% | -80.9% | -98.0% |
| Utilities | XLU | -7.90% | -16.5% | -91.0% | -108% |
| Aerospace & Defense | XAR | -7.36% | -20.6% | -92.5% | -118% |
| Biotech | XBI | 0.54% | -14.2% | -62.1% | -77.0% |
| Homebuilder | XHB | -6.82% | -17.0% | -69.6% | -83.1% |
| Retail | XRT | -7.24% | -17.5% | -76.9% | -85.7% |